share_log

Ginkgo Bioworks | 144: Notice of proposed sale of securities pursuant to Rule 144

Ginkgo Bioworks | 144: Notice of proposed sale of securities pursuant to Rule 144

Ginkgo Bioworks | 144:擬議出售證券
SEC announcement ·  03/14 10:39
Moomoo AI 已提取核心訊息
Ginkgo Bioworks Holdings, Inc. officer Che Austin is set to sell 3,968 Class A shares on 03/14/2024, with an aggregate market value of $4,563.20. The shares were originally acquired on 10/07/2022 as part of a restricted stock vesting agreement with the issuer, serving as compensation for Austin. This upcoming sale follows a series of transactions over the past three months, where a total of 242,048 shares were sold for gross proceeds of approximately $340,176.64. The notice of the planned sale was filed on the same day as the sale, 03/14/2024, with the plan for this transaction having been adopted a year prior on 03/14/2023.
Ginkgo Bioworks Holdings, Inc. officer Che Austin is set to sell 3,968 Class A shares on 03/14/2024, with an aggregate market value of $4,563.20. The shares were originally acquired on 10/07/2022 as part of a restricted stock vesting agreement with the issuer, serving as compensation for Austin. This upcoming sale follows a series of transactions over the past three months, where a total of 242,048 shares were sold for gross proceeds of approximately $340,176.64. The notice of the planned sale was filed on the same day as the sale, 03/14/2024, with the plan for this transaction having been adopted a year prior on 03/14/2023.
Ginkgo Bioworks Holdings, Inc.高管切·奧斯汀定於2024年3月14日出售3,968股A類股票,總市值爲4563.20美元。這些股票最初是在2022年7月10日收購的,是與發行人簽訂的限制性股票歸屬協議的一部分,作爲對奧斯汀的補償。此次即將進行的出售是在過去三個月進行的一系列交易之後進行的,共出售了242,048股股票,總收益約爲340,176.64美元。計劃出售的通知是在2024年3月14日與出售的同一天提交的,該交易的計劃是在一年前的2023年3月14日通過的。
Ginkgo Bioworks Holdings, Inc.高管切·奧斯汀定於2024年3月14日出售3,968股A類股票,總市值爲4563.20美元。這些股票最初是在2022年7月10日收購的,是與發行人簽訂的限制性股票歸屬協議的一部分,作爲對奧斯汀的補償。此次即將進行的出售是在過去三個月進行的一系列交易之後進行的,共出售了242,048股股票,總收益約爲340,176.64美元。計劃出售的通知是在2024年3月14日與出售的同一天提交的,該交易的計劃是在一年前的2023年3月14日通過的。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息